| Literature DB >> 29378029 |
S M Curry1, E R Burrough2, K J Schwartz2, K J Yoon2, S M Lonergan1, N K Gabler1.
Abstract
Porcine epidemic diarrhea virus (PEDV) infects enterocytes and in nursery pigs, results in diarrhea, anorexia, and reduced performance. Therefore, the objective of this study was to determine how PEDV infection influenced growth performance and repartitioning of amino acids and energy in nursery pigs. A total of 32 barrows and gilts, approximately 1 wk post-wean (BW = 8.46 ± 0.50 kg), and naïve for PEDV were obtained, weighed, and allotted based on sex and BW to one of two treatments: 1) Control, PEDV naïve and 2) PEDV-inoculated (PEDV) with eight pens of two pigs each per treatment. On day post-inoculation (dpi) 0, PEDV pigs were inoculated via intragastric gavage with PEDV isolate (USA/Iowa/18984/2013). Pig and feeder weights were recorded at dpi -7, 0, 5, and 20 in order to calculate ADG, ADFI, and G:F. Eight pigs per treatment were euthanized on dpi 5 and 20, and tissues and blood were collected. At dpi 5, all PEDV pigs were PCR positive for PEDV in feces. Overall, PEDV pigs tended (P < 0.10) to increase ADFI, which resulted in reduced (P < 0.05) feed efficiency. At dpi 5, PEDV pigs had reduced (P < 0.05) villus height and increased (P < 0.05) stem cell proliferation in the jejunum compared with Control pigs. Pigs inoculated with PEDV had increased (P < 0.05) serum haptoglobin and increased insulin-to-glucose ratios compared with Control pigs at dpi 5. Markers of muscle proteolysis were not different (P > 0.05) between treatments within dpi; however, at dpi 5, 20S proteasome activity was increased (P < 0.05) in longissimus dorsi of PEDV pigs compared with Control pigs. Liver and jejunum gluconeogenic enzyme activities were not different (P > 0.05) between treatments within dpi. Overall, PEDV-inoculated pigs did recover the absorptive capacity that was reduced during PEDV infection by increasing proliferation of intestinal stem cells. However, the energy and nutrients needed to recover the epithelium may be originating from available luminal nutrients instead of muscle proteolysis and gluconeogenesis. This study provides insight into the effects of an enteric coronavirus on postabsorptive metabolism in nursery pigs.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29378029 PMCID: PMC6140930 DOI: 10.1093/jas/skx005
Source DB: PubMed Journal: J Anim Sci ISSN: 0021-8812 Impact factor: 3.159
Diet composition, as-fed basis
| Ingredient | %, as-fed |
|---|---|
| Corn | 50.76 |
| Soybean meal, 48% CP | 19.00 |
| Soybean oil | 1.73 |
| Fishmeal, menhaden | 4.50 |
| Limestone | 0.35 |
| Whey, dried | 20.00 |
| Meat and bone meal | 2.04 |
|
| 0.43 |
|
| 0.16 |
|
| 0.13 |
|
| 0.03 |
|
| 0.07 |
| Salt | 0.40 |
| Vitamin–mineral premix1 | |
| Calculated composition | |
| ME, kcal/kg | 3,408 |
| SID Lys, % | 1.35 |
| STTD P, % | 0.40 |
SID, standardized ileal digestibility; STTD, standardized total tract digestibility.
1Premix supplied (per kg of diet): 8,820 IU vitamin A, 1,653 IU vitamin D3, 33.1 IU vitamin E, 4.4 mg vitamin K, 6.6 mg riboflavin, 38.9 mg niacin, 22.1 mg pantothenic acid, 0.04 mg vitamin B12, 1.1 mg I as potassium iodide, 0.30 mg Se as sodium selenite, 60.6 mg Zn as zinc oxide, 36.4 mg Fe as ferrous sulfate, 12.1 mg Mn as manganous oxide, and 3.6 mg Cu as copper sulfate.
PEDV detection in feces of pig inoculation with PEDV at dpi 2, 5, 10, 15, and 201
| Parameter | Dpi | SEM |
| ||||
|---|---|---|---|---|---|---|---|
| 2 | 5 | 10 | 15 | 20 | |||
| Ct2 | 29.15a | 21.01b | 31.52a | 32.69a | 33.50a | 1.826 | <0.001 |
| Positive/Total | |||||||
| PCR3 | 5/8 | 8/8 | 6/8 | 2/8 | 1/8 | – | – |
| ISH4 | – | 7/8 | – | – | 0/8 | – | – |
| IHC5 | – | 7/8 | – | – | 0/8 | – | – |
1Control pigs remained negative for PEDV throughout the duration of the study.
2Ct, cycle threshold. Ct value ≥35 is considered negative for PEDV.
3Positive pigs out of total pigs swabbed at that dpi. Pigs were considered positive for PEDV presence in feces when Ct <35.
4Positive pigs were those that PEDV nucleic acid was detected in the jejunum.
5Positive pigs were those that PEDV protein was detected in the jejunum.
a,bMeans without a common superscript differ (P ≤ 0.05).
Figure 1.Western blot of intact µ-calpain illustrated by the 80-kilodalton band and autolyzed 78- and 76-kilodalton bands.
Growth performance of naïve (Control) and pigs inoculated with PEDV over 20 d1
| Parameter, kg | Treatment | SEM |
| |
|---|---|---|---|---|
| Control | PEDV | |||
| Start BW | 8.06 | 8.85 | 0.496 | 0.280 |
| End BW | 17.89 | 17.72 | 1.051 | 0.912 |
| Dpi 1–5 | ||||
| ADG | 0.28 | 0.18 | 0.049 | 0.156 |
| ADFI | 0.39 | 0.35 | 0.047 | 0.493 |
| G:F | 0.70 | 0.45 | 0.077 | 0.039 |
| Dpi 6–20 | ||||
| ADG | 0.55 | 0.52 | 0.034 | 0.433 |
| ADFI | 0.63 | 0.79 | 0.053 | 0.047 |
| G:F | 0.90 | 0.66 | 0.050 | 0.003 |
| Dpi 0–20 | ||||
| ADG | 0.49 | 0.44 | 0.033 | 0.328 |
| ADFI | 0.57 | 0.68 | 0.043 | 0.088 |
| G:F | 0.88 | 0.66 | 0.046 | 0.004 |
1Estimates are represented by eight pens per treatment.
Morphology, stem cell proliferation, and lesion scores in the jejunum of naïve (Control) and PEDV-inoculated pigs at dpi 5 and 201
| Parameter | Dpi | SEM |
| |||||
|---|---|---|---|---|---|---|---|---|
| 5 | 20 | |||||||
| Control | PEDV | Control | PEDV | trt | dpi | trt × dpi | ||
| Morphology | ||||||||
| VH, µm | 288b | 190c | 348a | 355a | 15.310 | 0.006 | <0.001 | 0.002 |
| CD, µm | 255 | 219 | 232 | 240 | 15.260 | 0.958 | 0.373 | 0.662 |
| VH:CD | 1.31x | 0.88y | 1.53x | 1.57x | 0.119 | 0.110 | <0.001 | 0.054 |
| Ki672 | 43c | 57a | 49b | 52b | 1.446 | <0.001 | 0.493 | 0.001 |
| Protein3, % | 6.96ab | 6.15b | 6.80ab | 7.68a | 0.331 | 0.904 | 0.048 | 0.017 |
| RNA3, % | 0.13 | 0.14 | 0.14 | 0.14 | 0.017 | 0.581 | 0.536 | 0.877 |
| Protein:RNA | 57.81x | 45.94y | 42.28y | 51.87xy | 5.277 | 0.831 | 0.373 | 0.053 |
| Lesion scores4 | ||||||||
| 0 | 4/8 | 0/8 | 3/8 | 6/8 | – | – | – | <0.001 |
| 1 | 4/8 | 1/8 | 5/8 | 2/8 | – | – | – | – |
| 2 | 0/8 | 5/8 | 0/8 | 0/8 | – | – | – | – |
| 3 | 0/8 | 2/8 | 0/8 | 0/8 | – | – | – | – |
trt, treatment; CD, crypt depth.
1Represented by eight observations per treatment per time.
2Cells positive for Ki67 were counted in three intact villi of correct orientation and an average per villus was calculated. Ki67 is a marker for stem cell proliferation.
3Represented as a percent (g/g) of tissue.
4Lesion score: 0 = normal; 1 = mild villus blunting with rare fusion; 2 = moderate villus blunting and fusion with lymphoid infiltration; 3 = severe villus blunting and fusion with lymphoid infiltration. The interaction of treatment and dpi significantly influenced lesion score in the jejunum as determined by Fisher’s exact test.
a,bMeans without a common superscript differ (P ≤ 0.05); x,yMeans without a common superscript differ (P < 0.10).
Serum parameters in naïve (Control) and PEDV-inoculated pigs at dpi 5 and 201
| Parameter | Dpi | SEM |
| |||||
|---|---|---|---|---|---|---|---|---|
| 5 | 20 | |||||||
| Control | PEDV | Control | PEDV | trt | dpi | trt × dpi | ||
| Glucagon, pg/mL | 132 | 135 | 205 | 148 | 25.517 | 0.304 | 0.104 | 0.252 |
| Glucose, mg/dL | 96b | 83b | 105b | 130a | 8.002 | 0.463 | 0.002 | 0.024 |
| Insulin, ng/mL | 0.09b | 0.18b | 0.17b | 0.51a | 0.044 | <0.001 | <0.001 | 0.010 |
| Insulin:glucose2 | 2.60c | 7.29b | 4.57bc | 11.18a | 1.203 | <0.001 | 0.021 | 0.433 |
| NEFA, mEq/L | 0.16a | 0.20a | 0.09b | 0.09b | 0.023 | 0.534 | 0.005 | 0.473 |
| BUN, mg/dL | 6.78a | 5.68ab | 6.46ab | 4.81b | 0.599 | 0.030 | 0.328 | 0.643 |
| Haptoglobin, µg/mL | 280y | 460x | 240y | 224y | 57.350 | 0.162 | 0.023 | 0.100 |
trt, treatment.
1Estimates are represented by eight observations per treatment per time.
2Units in mol:mol/L × 10–9.
a,bMeans without a common superscript differ (P ≤ 0.05); x,yMeans without a common superscript differ (P < 0.10).
Proteolysis markers in LD of naïve (Control) and PEDV-inoculated pigs at dpi 5 and 201
| Parameter | Dpi | SEM |
| |||||
|---|---|---|---|---|---|---|---|---|
| 5 | 20 | |||||||
| Control | PEDV | Control | PEDV | trt | dpi | trt × dpi | ||
| Calpastatin, AU2 | 1.00 | 1.05 | 0.40 | 0.77 | 0.125 | 0.092 | <0.001 | 0.201 |
| µ-Calpain,3 % | ||||||||
| 80 kDa | 44.28 | 47.54 | 54.18 | 52.84 | 3.802 | 0.802 | 0.051 | 0.548 |
| 78 kDa | 18.74 | 16.03 | 26.42 | 28.03 | 3.259 | 0.865 | 0.004 | 0.511 |
| 76 kDa | 36.98 | 36.44 | 19.40 | 19.14 | 3.408 | 0.907 | <0.001 | 0.967 |
| Myofibrillar protein,4 mg | 31.78 | 32.89 | 23.68 | 24.35 | 2.250 | 0.696 | 0.009 | 0.921 |
| ERMs, mg | 0.06 | 0.06 | 0.05 | 0.07 | 0.01 | 0.303 | 0.698 | 0.247 |
| ERMs,5 % | 0.20 | 0.20 | 0.22 | 0.31 | 0.041 | 0.324 | 0.112 | 0.325 |
| Protein:RNA | 24.69 | 26.31 | 25.20 | 23.29 | 2.807 | 0.958 | 0.659 | 0.534 |
| 20S proteasome6 | 20.97b | 28.59a | 17.24b | 9.81c | 2.477 | 0.970 | <0.001 | 0.005 |
trt, treatment.
1Estimates are represented by eight observations per treatment per time.
2AU = arbitrary units relative to Control at dpi 5.
3Protein density percentages of unautolyzed 80 kilodalton µ-calpain subunit and its 78 and 76 kilodalton subunit autolysis products.
4Obtained from 1.5 g frozen LD.
5Represented as a percent of crude myofibrillar protein extraction.
620S proteasome activity measured as micromolar (µM) of released fluorescent 7-amino-4-methylcoumarin (AMC) from LLVY-AMC per mg protein.
a,bMeans without a common superscript differ (P ≤ 0.05).
Gluconeogenic enzymatic activity in liver and jejunum mucosal scrapings of naïve (Control) and PEDV-inoculated pigs at dpi 5 and 201
| Parameter | Dpi | SEM |
| |||||
|---|---|---|---|---|---|---|---|---|
| 5 | 20 | |||||||
| Control | PEDV | Control | PEDV | trt | dpi | trt × dpi | ||
| Liver | ||||||||
| PEPCK | 1.00 | 0.97 | 1.20 | 1.20 | 0.087 | 0.829 | 0.018 | 0.893 |
| F1,6BP | 1.56 | 1.52 | 0.62 | 0.90 | 0.202 | 0.571 | <0.001 | 0.439 |
| G6P | 0.12ab | 0.15a | 0.12ab | 0.06b | 0.023 | 0.591 | 0.042 | 0.043 |
| Jejunum | ||||||||
| PEPCK | 68.74 | 65.27 | 61.10 | 64.53 | 15.127 | 0.999 | 0.784 | 0.822 |
| F1,6BP | 16.12x | 11.00xy | 13.22y | 12.66y | 1.165 | 0.021 | 0.598 | 0.060 |
| G6P | 1.13 | 1.08 | 1.16 | 1.13 | 0.107 | 0.724 | 0.699 | 0.902 |
PEPCK, phosphoenolpyruvate carboxykinase (µM ATP/min/g tissue); F1,6BP, fructose 1,6-bisphosphatase (µM NADPH/min/g tissue); G6P, glucose-6-phosphatase (mM Pi released/min/g tissue).
1Estimates are represented by eight observations per treatment per time.
a,bMeans without a common superscript differ (P ≤ 0.05). x,yMeans without a common superscript differ (P < 0.10).